
d1000 Varejo Farma S.A.
B3-listed Brazilian drugstore operator (DMVF3) owned by Grupo Profarma, running Drogasmil, Farmalife, Tamoio and Drogaria Rosário.
Company Type
public
Founded
2013
Headquarters
Rio de Janeiro, Rio de Janeiro, Brazil
Stock
B3 (Brasil, Bolsa, Balcão): DMVF3
Revenue
R$2.2 billion gross revenue (FY2024)
Employees
Approximately 4,100
Primary Market
Regional
d1000 Varejo Farma S.A. Timeline
Shop d1000 Varejo Farma S.A. Brands
Disclosure: We may earn commission from purchasesAbout d1000 Varejo Farma S.A.
What is Rede d1000?
The retail drugstore company of Grupo Profarma, operating the Drogasmil, Farmalife, Drogarias Tamoio and Drogaria Rosário banners across Rio de Janeiro, the Federal District and Mato Grosso.
Is d1000 publicly traded?
Yes. d1000 Varejo Farma S.A. lists on the B3 Novo Mercado under ticker DMVF3, having gone public in 2020.
Who controls d1000?
Grupo Profarma, the Brazilian pharmaceutical group listed under PFRM3, is the controlling shareholder and operates one of the country's largest drug distributors.
How many stores does Rede d1000 operate?
276 stores as of the end of 2024, serving more than 2.5 million customers per month with about 4,100 employees.
What was d1000's revenue in 2024?
Gross revenue of R$2.2 billion, up 20.3 percent versus 2023, with record adjusted EBITDA of R$82.2 million.
History of d1000 Varejo Farma S.A.
The company was created in 2013 when Grupo Profarma consolidated three retail pharmacy acquisitions: Drogasmil, Farmalife and Drogarias Tamoio, all Rio de Janeiro chains with decades of regional presence. A year later Profarma acquired Drogaria Rosário of Brasília for more than R$173 million, extending the platform into the Federal District and the Central-West.
The strategic logic paired retail with Profarma's distribution scale. Daily deliveries from the distributor's own warehouses reduced store-level working capital, centralized administrative services through a shared service center, and gave the group bargaining power as one of the top three private-sector pharmaceutical buyers in Brazil.
In 2020 the retail arm listed on B3's Novo Mercado, the exchange's highest governance tier, under ticker DMVF3 as d1000 Varejo Farma S.A. The listing formalized the separation between Profarma's distribution business and the retail network.
Post-listing growth has been consistent. For three consecutive years through 2024 the company grew revenue at least twice the national pharmacy retail average, reaching R$2.2 billion in 2024 gross revenue, up 20.3 percent, with record adjusted EBITDA of R$82.2 million. The store base reached 276 locations, beating expansion guidance, while store remodeling, CRM programs and e-commerce lifted average ticket per store. The company ranked as the most efficient pharmacy retailer in the IBEVAR-FIA 2024 study for the second consecutive year.
d1000 Varejo Farma S.A. Sustainability & Ethics
The company publishes an annual sustainability report within the Profarma group ESG framework, covering pharmaceutical waste handling, responsible marketing of medicines and social programs in its operating regions. Its multi-banner model emphasizes accessibility across income classes, positioning the network as a popular-priced alternative to premium chains.
Controversy, Regulation & Public Scrutiny
The Rosário acquisition passed review by CADE, Brazil's antitrust authority, in 2014 without structural remedies. The company maintains a clean regulatory record since listing, operating under ANVISA pharmaceutical retail regulations and Novo Mercado governance requirements.
Brands Owned by d1000 Varejo Farma S.A.
d1000 Varejo Farma S.A. owns 1 brand in our database. Explore the ownership tree below — click categories to expand and see individual brands.
d1000 Varejo Farma S.A.
public · Founded 2013 · Rio de Janeiro, Rio de Janeiro, Brazil
1
brands
Stock Information
d1000 Varejo Farma S.A. Ownership: Pros & Cons
Advantages
- +Profarma distribution integration cuts working capital and improves margins
- +Regional brands retain decades of local customer loyalty
- +Novo Mercado listing enforces strong governance standards
- +Consistent above-market revenue growth for three consecutive years
Considerations
- -Controlled company structure limits minority shareholder influence
- -Regional concentration in Rio and the Central-West
- -Scale disadvantage against national leaders RD and Pague Menos
- -Thin pharmacy retail margins leave little room for execution errors
Frequently Asked Questions About d1000 Varejo Farma S.A.
What is Rede d1000?
The retail drugstore company of Grupo Profarma, operating the Drogasmil, Farmalife, Drogarias Tamoio and Drogaria Rosário banners across Rio de Janeiro, the Federal District and Mato Grosso.
Is d1000 publicly traded?
Yes. d1000 Varejo Farma S.A. lists on the B3 Novo Mercado under ticker DMVF3, having gone public in 2020.
Who controls d1000?
Grupo Profarma, the Brazilian pharmaceutical group listed under PFRM3, is the controlling shareholder and operates one of the country's largest drug distributors.
How many stores does Rede d1000 operate?
276 stores as of the end of 2024, serving more than 2.5 million customers per month with about 4,100 employees.
What was d1000's revenue in 2024?
Gross revenue of R$2.2 billion, up 20.3 percent versus 2023, with record adjusted EBITDA of R$82.2 million.






